Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effectiveness of Intranasal Dexmedetomidine for Sedated Auditory Brainstem Response in Children
2018-001466-42Phase 2Completed
- Sponsor
- Fondation Lenval
- Start
- Apr 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, single-arm trial of dexmedetomidine in Hypoacusis, specific language impairment (DLD), Global Developmental Delay (GDD) and 1 more, sponsored by Fondation Lenval. Primary endpoint: Primary effectiveness endpoint. Started Apr 2018; status: completed.
02
Drugs
dexmedetomidine
03
Conditions
Hypoacusisspecific language impairment (DLD)Global Developmental Delay (GDD)
Beyond the preview
Go deeper on 2018-001466-42.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2018-001466-42.